Nebula Royale
A purple-tinged Nebula descendant marketed as a regal hybrid, with limited verifiable data behind the name.
Nebula Royale is a boutique-tier name attached to the older Paradise Seeds 'Nebula' line. There is no peer-reviewed work on this specific cross, no independent lab panel published by a third party, and lineage details vary between vendors. What you can trust: it descends from Nebula, which is a documented Paradise Seeds release. Almost everything else — exact parentage, terpene dominance, 'royal' euphoria claims — is marketing copy, not data.
Overview
Nebula Royale is sold by a handful of seed banks and dispensaries as a refined or 'royal' version of the original Nebula, a Paradise Seeds release from the late 1990s [1]. The 'Royale' suffix is common in modern cannabis marketing and typically signals a vendor's own selection or backcross rather than a distinct, stabilized line. No data
Because there is no central registry for strain names, two products labeled 'Nebula Royale' from different sellers may not share genetics. Treat the name as a brand cue, not a guarantee of consistent chemistry or phenotype. See Strain Names Are Not Standardized for background.
Chemistry: cannabinoids and terpenes
No peer-reviewed chemotype analysis of Nebula Royale exists at the time of writing. No data Vendor pages typically list THC around 18–22% and negligible CBD, which is in line with most modern Type I (THC-dominant) hybrids [2].
Terpene claims vary. Some listings call out myrcene; others list terpinolene or caryophyllene. Without batch-level certificates of analysis from a regulated lab, these are not verifiable. The popular idea that any sample above '0.5% myrcene' is automatically sedating is folklore — it traces to a single often-repeated blog claim and is not supported by controlled human studies [3]. Disputed
If you care about chemistry, ask the dispensary for the actual lab COA for the batch in front of you. The strain name will not tell you what is in the jar.
Reported effects
There are no clinical trials on Nebula Royale, and there are essentially none on individual strains in general. No data Reviews on consumer sites describe a euphoric, talkative onset shifting to body relaxation, sometimes with appetite stimulation Anecdote.
These descriptions are consistent with what most THC-dominant hybrids produce at moderate doses, and they are heavily shaped by expectation, set, setting, and dose [4]. The 'indica vs sativa predicts effects' framing that vendors lean on is not supported by chemotype data: chemical profiles within those labels overlap heavily [5]. Strong evidence
Expect THC-typical effects: euphoria, altered time perception, dry mouth, increased heart rate, possible anxiety at higher doses. Start low.
Lineage
The parent strain, Nebula, is documented by Paradise Seeds as a cross involving Master Widow and a US Haze line, released around 1996 and winning a High Times Cannabis Cup category in 1999 [1][6].
Nebula Royale's parentage is disputed. Different vendors describe it variously as:
- A Nebula selfed/S1 selection
- A Nebula × Purple parent (to explain the purple coloration the name implies)
- A backcross of Nebula to itself for stability
None of these are backed by a published breeder log with verifiable provenance. Disputed If lineage matters to you (for example, for breeding work), contact the specific seed bank and ask for their pedigree records in writing.
Cultivation basics
Based on vendor descriptions and the behavior of the parent Nebula line [1]:
- Flowering time: roughly 9–10 weeks indoor; outdoor harvest typically early to mid October in the Northern Hemisphere.
- Structure: medium height, moderate stretch after flip; responds to topping and light defoliation.
- Yield: vendor estimates of 450–550 g/m² indoor are typical hybrid-range claims; real-world yields depend far more on light, VPD, and grower skill than on genetics Weak / limited.
- Sensitivities: Nebula-line plants are reported to prefer moderate feeding; heavy nitrogen late in veg can delay flower transition Anecdote.
- Purple expression: cooler night temperatures in late flower can pull anthocyanin color forward in many cultivars, independent of cannabinoid content [7].
Difficulty is moderate — not a beginner plant, not a connoisseur-only project.
Marketing vs. reality
What's real:
- Nebula (the parent) is a documented, awarded Paradise Seeds release [1][6].
- THC-dominant hybrids in this range will produce predictable THC-type effects at typical doses.
What's marketing:
- The 'Royale' suffix implies a refined or aristocratic version. There is no industry standard for that label.
- Specific terpene percentages, effect profiles, and medical benefits attached to the name on vendor pages are not backed by independent analysis. No data
- Claims that a particular strain reliably treats specific conditions are not supported by clinical evidence at the strain level [5][8]. Strong evidence
Buy it because you like the specific batch's COA and smell, not because of the name on the label.
Sources
- Practitioner Paradise Seeds. Nebula strain page (breeder catalog).
- Peer-reviewed ElSohly, M. A., Mehmedic, Z., Foster, S., Gon, C., Chandra, S., & Church, J. C. (2016). Changes in cannabis potency over the last two decades (1995–2014). Biological Psychiatry, 79(7), 613–619.
- Peer-reviewed Russo, E. B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344–1364.
- Peer-reviewed Gukasyan, N., & Strickland, J. C. (2023). Contextual and pharmacological influences on subjective effects of cannabis. Current Opinion in Psychology, 51, 101582.
- Peer-reviewed Smith, C. J., Vergara, D., Keegan, B., & Jikomes, N. (2022). The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE, 17(5), e0267498.
- Reported High Times. Cannabis Cup historical winners archive.
- Peer-reviewed Liu, Y., Tikunov, Y., Schouten, R. E., Marcelis, L. F. M., Visser, R. G. F., & Bovy, A. (2018). Anthocyanin biosynthesis and degradation mechanisms in plants. Frontiers in Chemistry, 6, 52.
- Government National Academies of Sciences, Engineering, and Medicine (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Myrcene — The most common monoterpene in cannabis, blamed and credited for a lot of things it probab...